Medtronic has secured the US Food and Drug Administration (FDA) approval for its Claria MRI Quad Cardiac Resynchronisation Therapy Defibrillator (CRT-D) SureScan device for patients with heart failure.

Approved for scanning in both 1.5 and 3 Tesla (T) magnetic resonance imaging (MRI) machines, the Claria device features a new algorithm, EffectivCRT, which automatically customises the therapy to individual patients by adjusting pacing rates.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Arrhythmia Institute of the Valley Health System electrophysiology laboratory director Suneet Mittal said: "Until now, CRT devices have shown only whether a pacing pulse was sent, but we have not been able to determine if that stimulation actually improves the heart's pumping ability.

"The device is incorporated with the AdaptivCRT algorithm which minimises the chance of a patient’s heart failure readmission by 59% and has reduced 46% atrial fibrillation risk."

"With the Claria device, physicians are now able to verify the effectiveness of left ventricular pacing, which is especially beneficial for improving outcomes in patients with atrial fibrillation, who have been difficult to treat because this irregular and rapid heartbeat often interferes with the delivery of effective CRT."

Among other features, the device is incorporated with the AdaptivCRT algorithm which minimises the chance of a patient’s heart failure readmission by 59% and has reduced 46% atrial fibrillation risk.

The Claria device includes the automated in-office VectorExpress test which decreases lead programing to two minutes and reveals clinically actionable information to enable physicians choose optimal pacing configurations for each patient.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The Attain Perfoma MRI SureScan Quadripolar Leads features short bipolar spacing to reduce phrenic nerve stimulation occurrence, steroid on all electrodes, and three shapes to accommodate different patient anatomies.

The device also features SureScan MR-conditional labeling for full-body scans without positioning restrictions.